The federal investigation into the deadly anthrax mailings of late 2001 was undermined by leaks and a premature fixation on a single suspect, according to investigators involved in the case.
Read more
A British company is now a leading contender in the federal
government’s search for a better anthrax vaccine.
Read more
![]()
Michael
K. Deaver, the media maestro who choreographed the look of
the Reagan presidency, forever changing the way presidents are
presented to the public, died Saturday at home in Bethesda, Md.
Read more
![]()
In the fall of 1992, Kanatjan Alibekov defected from Russia to the
United States, bringing detailed, and chilling, descriptions of his
role in making biological weapons for the former Soviet Union.
Read more
![]()
A senior researcher at the National Institutes of Health, who became
a symbol of the agency’s improper entanglements with drug companies
and whose lasting presence on the federal payroll enraged members of
Congress, has retired from the government.
Read more
A bipartisan group of congressional leaders is examining the Food and
Drug Administration’s contract awards to a company that has paid
consulting fees and salary to the husband of a senior agency official.
Read more
A congressional subcommittee chairman and a top administrator of the
National Institutes of Health agreed on at least one point Wednesday:
Private financial deals between drug companies and
NIH scientists
that have come to light in recent years have posed the worst scandal
in the agency’s history.
Read more
